DT56a
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
To determine the metabolic and immunological effects of the oral administration of DT56a, an enzymatic isolate of soybeans.
Background: Hormone therapy (HT) is the treatment of choice for the alleviation of menopausal symptoms; concerns, however, about…
Objective:The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on…
Background: We demonstrated previously that phytoestrogens and vitamin D analogs like estradiol-17β (E2) modulate bone morphology…
Objective: The natural selective estrogen receptor modulator DT56a (Femarelle), derived from soybean, has been shown to relieve…
Objective DT56a is a natural compound for the treatment of menopausal symptoms and osteoporosis. The aim of this study was to…
OBJECTIVE
In a previous study treatment with a daily standard dose of Femarelle (644 mg/day) resulted in a significant elevation…